Product Information
IBUPROFEN 100 MG/5 ML SUSP is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.0243 per ML under NDC 45802095243. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Sep 23, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/5mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802095243
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA076925FDA Approved
9/23/2004
TE Code
AB
On Market Since
12/8/2004
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 100 MG/5 ML SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 44.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0243 per ML |
|---|---|
| All-time high | $0.0557 (Aug 12, 2015) |
| All-time low | $0.0185 (Nov 20, 2024) |
| 52-week high | $0.0256 |
| 52-week low | $0.0236 |
| Median price | $0.0358 |
| Average price | $0.0365 |
| Largest weekly change | +33.6% (May 18, 2022) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 100 MG/5 ML SUSP, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.0243 per ML (NDC 45802095243), effective Aug 19, 2026.
How has the price of IBUPROFEN 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has declined 44.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 100 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has ranged from a low of $0.0185 (Nov 20, 2024) to a high of $0.0557 (Aug 12, 2015), with a median of $0.0358 per ML.
Are there cheaper alternatives to IBUPROFEN 100 MG/5 ML SUSP?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 100 MG/5 ML SUSP, is $0.0239 per ML — about 1% below IBUPROFEN 100 MG/5 ML SUSP.
Who manufactures IBUPROFEN 100 MG/5 ML SUSP?
IBUPROFEN 100 MG/5 ML SUSP (NDC 45802095243) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.